Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Strainsforpains Inc EBYH

Strainsforpains, Inc. is a data aggregation and technology company, which is focused on the global medical cannabis market. The Company's business operations consist of application technology, providing wellness and health solutions, which guides health professionals and patients in making decisions regarding cannabis and cannabidiol (CBD) usage for pain relief. Its principal service is its Strainsforpains App, that is based on medical cannabis and CBD research. The Strainsforpains App is a recommendation engine that guides patients and health professionals to the appropriate cannabinoid levels, medical cannabis strains, and consumption methods for a specific ailment or pain. The Strainsforpains App is accessible through a mobile application, and desktop application, and it utilizes a database of strains, cannabinoids, and medicinal applications aggregated through semantic Web technology and validated by medical devices in research centers around the world.


PINL:EBYH - Post by User

Post by CashSeekeron May 14, 2024 9:14am
46 Views
Post# 36038410

$EBYH - CEO Discusses Entering 191 Billion Dollar Anti-Infl

$EBYH - CEO Discusses Entering 191 Billion Dollar Anti-Infl
 
$EBYH - Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
 
 
$EBYH - Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
 
 
<< Previous
Bullboard Posts
Next >>